Jiro Nakamura

Confirmation of Multiple Risk Loci and Genetic Impacts by a Genome-Wide Association Study of Type 2 Diabetes in the Japanese Population

Fumihiko Takeuchi, Masakuni Serizawa, Ken Yamamoto et al. · Diabetes · 2009 · 235 citations · Full text

A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats.

Jiro Nakamura, Koichi Kato, Yuichi Hamada et al. · Diabetes · 1999 · 225 citations

Social Sciences, Oxidative Stress, Molecular Pharmacology +20

Transplantation of Bone Marrow–Derived Mesenchymal Stem Cells Improves Diabetic Polyneuropathy in Rats

Taiga Shibata, Keiko Naruse, Hideki Kamiya et al. · Diabetes · 2008 · 192 citations · Full text

Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial

Daisuke Yabe, Jiro Nakamura, Hideaki Kaneto et al. · The Lancet Diabetes & Endocrinology · 2020 · 182 citations

Diabetes Management, Cardiovascular Disease, Medicine +8

Rapid Formation of Advanced Glycation End Products by Intermediate Metabolites of Glycolytic Pathway and Polyol Pathway

Yoji Hamada, Norie Araki, Naoki Koh et al. · Biochemical and Biophysical Research Communications · 1996 · 168 citations

Glycolytic Pathway, Rapid Formation, Biotransformation +7